EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole brain radiation therapy for patients with brain metastases: survival outcomes and prognostic factors in a contemporary institutional series

Anna Estermann, Chiara Schneider, Frank Zimmermann, Alexandros Papachristofilou, Tobias Finazzi iD

Strahlentherapie und Onkologie · 2024-11 · 200 (11) · 942-948

DOI: 10.1007/s00066-024-02275-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Strahlentherapie und Onkologie, online erschienen am 12.08.2024. Verfasst von Anna Estermann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. Hauptthemen laut MEDLINE: Brain Neoplasms, Cranial Irradiation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Basel.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To study survival outcomes and prognostic factors in patients undergoing whole brain radiation therapy (WBRT) for brain metastases in the contemporary setting.

Methods

Patients undergoing WBRT from 2013–2021 were retrospectively included in an ethics-approved institutional database. Patient and treatment characteristics were assessed, including patient age, primary tumor histology, Karnofsky Performance Status (KPS), extracranial disease, as well as WBRT dose. Overall survival (OS) was calculated from onset of WBRT using the Kaplan-Meier method.

Results

A total of 328 patients (median age 63 years) were included. Most patients (52%) had ≥ 10 brain metastases, and 17% had leptomeningeal disease. WBRT was delivered with 10 × 3 Gy (64%), 5 × 4 Gy (25%), or other regimens (11%). Median follow-up was 4.4 months (range, 0.1–154.3), and median OS was 4.7 months (95%CI, 3.8–6.0). OS differed between histologies ( p = 0.01), with the longest survival seen in breast cancer (median 7.7 months). Patients with KPS of 90–100 survived for a median of 8.3 months, compared to 4.1 months with KPS 70–80, and 1.7 months with KPS < 70 ( p < 0.01). Multivariate analyses revealed that KPS had the largest impact on survival. Patients who received a WBRT dose of ≥ 30 Gy also had a reduced risk of death (HR 0.45; p < 0.001). Survival differed between subgroups reclassified according to the Rades scoring system ( p < 0.01).

Conclusion

Survival outcomes of patients undergoing WBRT in the contemporary era appear comparable to historical cohorts, although individual patient factors need to be considered. Patients with otherwise favorable prognostic factors may benefit from longer-course WBRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCranial IrradiationHumansMiddle AgedFemaleMaleAgedPrognosisRetrospective StudiesAdultAged, 80 and overKarnofsky Performance StatusKaplan-Meier EstimateSurvival RateRadiotherapy DosageTreatment Outcome

Stichwörter der Autor:innen

Brain metastasesWBRTWhole brain radiation therapyWhole brain radiotherapy

Autor:innen und Institutionen

  • Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
  • Clinic of Radiotherapy and Radiation Oncology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. tobias.finazzi@usb.ch.
  • Department of Radiation Oncology, Kantonsspital Baden, Baden, Switzerland. tobias.finazzi@usb.ch.

ORCID-Profile: Tobias Finazzi

Förderung

  • University of Basel

Zitieren

APA

Estermann, A., Schneider, C., Zimmermann, F., Papachristofilou, A., & Finazzi, T. (2024). Whole brain radiation therapy for patients with brain metastases: survival outcomes and prognostic factors in a contemporary institutional series. Strahlentherapie und Onkologie, 200(11), 942-948. https://doi.org/10.1007/s00066-024-02275-x

Vancouver

Estermann A, Schneider C, Zimmermann F, Papachristofilou A, Finazzi T. Whole brain radiation therapy for patients with brain metastases: survival outcomes and prognostic factors in a contemporary institutional series. Strahlentherapie und Onkologie. 2024;200(11):942-948. doi:10.1007/s00066-024-02275-x

BibTeX
@article{Estermann2024,
  author = {Estermann, Anna and Schneider, Chiara and Zimmermann, Frank and Papachristofilou, Alexandros and Finazzi, Tobias},
  title = {Whole brain radiation therapy for patients with brain metastases: survival outcomes and prognostic factors in a contemporary institutional series},
  journal = {Strahlentherapie und Onkologie},
  year = {2024},
  volume = {200},
  number = {11},
  pages = {942--948},
  doi = {10.1007/s00066-024-02275-x}
}
Kostenlos starten →